Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-01-31
1995-11-21
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 80, 544337, 544344, 568327, A61K 31495, C07D49110, C07D49510, C07D24138
Patent
active
054687489
ABSTRACT:
The present invention relates to 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof which are useful in treating neurological and psychiatric diseases based on the antagonism of the glycine binding site on the NMDA receptor complex.
REFERENCES:
patent: 4889855 (1989-12-01), Jacobsen et al.
patent: 4912108 (1990-03-01), Jacobsen et al.
patent: 5026704 (1991-06-01), Honore et al.
patent: 5081123 (1992-01-01), Honore et al.
patent: 5153195 (1992-10-01), Honore et al.
patent: 5182279 (1993-01-01), Jorgensen et al.
Bergel et al., "Journal of Chemical Society", 1964, University College, (London), pp. 3973-3981.
A. W. Johnson et al., "Journal of Chemical Society", 1960, University College, (London), pp. 3412-3413.
Faarup Peter
Jakobsen Palle
Jorgensen Anker S.
Klitgaard Henrik
LandOfFree
9H-indeno[1,2-b]pyrazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 9H-indeno[1,2-b]pyrazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 9H-indeno[1,2-b]pyrazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137315